Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Hyberbaric Oxygen Therapy
- Abstract
- Hyperbaric Oxygen Therapy (HBOT) is a treatment modality using oxygen breathed under high pressure. The expected therapeutic benefits are: increase in diffusion of oxygen into tissues adjacent to the microcirculation and thus, the survival of cells otherwise insufficiently oxygenated, generalised arteriolar vasoconstriction, anti-infectious effects, promotion of healing. Introduced in the medical therapeutic armament in the early sixties, HBOT has been widely used before its development became restrained by an insufficient pathophysiological knowledge and some technical concerns.
The main objective of the Action is to improve the knowledge required for a rational use of HBOT, to a level making it possible to set out specific guidelines for the implementation and development of clinical HBOT centres and to provide scientifically sound recommendations for HBOT treatment of various diseases and conditions.
The COST B14 Action is implemented through 3 working groups (WG) devoted to the development of :
- a « Information Network », to be maintained throughout the duration of the Action (WG A).
In this frame, a study was performed. The aim of the study was : `Collecting, indexing and analysis of all relevant publications at the European level on Hyperbaric Oxygen Therapy and setting up a database`.
- a « Research Guidance Document » specifying the quality criteria desired for any new and ongoing research projects on HBOT, based on the analysis of existing research data and of the weight of the available scientific data (WG B).
- a « Research Priority Report », defining areas needing further clarification urgently, that will serve as a basis for directed clinical and experimental research (WG C).
- Lokale Teilprojektleitung:
-
Ratzenhofer-Komenda Beatrice
- Laufzeit:
- 01.03.2000-01.03.2005
- Programm:
- EU COST
- Mitarbeiter*innen
- Ratzenhofer-Komenda, Beatrice, Projektleiter*in
- Beteiligte MUG-Organisationseinheiten
-
Universitätsklinik für Anästhesiologie und Intensivmedizin
- Projektpartner
-
Assaf - HAROFE - Orthopedic and HBO Medical Dpt. - Zriffin - Israel, Israel
Kontaktperson: Gal Nachom, MD
Nachom Halperin, MD;
-
Azienda Opedaliera Pisa, Italien
Kontaktperson: Giuseppe De Iaco, MD;
-
CE.M.I.S., Italien
Kontaktperson: Roberto Pruiti, MD;
-
Centro di Medicina Iperbarica, Istituto di Anestesia e Rianimazione-Universitá "La Sapienza", Italien
Kontaktperson: Prof. Monica Rocco;
-
Centro die Medicina Subacquea ed Iperbarica, Italien
Kontaktperson: Paolo Della Torre, MD;
-
Centro Iperbarico srl, Italien
Kontaktperson: Pasquale Longobardi, MD;
-
Centro OTI "Nautilus"
, Italien
Kontaktperson: Gianmarco Oppo, MD;
-
HBO Centre - Hopital Militaire Reine Astrid, Belgien
Kontaktperson: Peter Germonprè, MD;
-
Instituto Fisiochinesiterapico, Italien
Kontaktperson: Dr. Roberto Rusconi;
-
Iper srl, Italien
Kontaktperson: Claudio Luongo, MD;
-
Istituto Iperbarico, Italien
Kontaktperson: Lorenzo Cucci, MD;
-
Ospedale Fidenza Servizio di Anestesia e Rianimazione, Italien
Kontaktperson: Prof. Giuliano Vezzani;
-
Ospedale La Maddalena, Italien
Kontaktperson: Carlo Randaccio, MD;
-
Ospedale Marino, Italien
Kontaktperson: Paolo Castaldi, MD
Cesare Iesu, MD;
-
OTI Medicale Vecenza srl, Italien
Kontaktperson: Luciano Ditdri, MD;
-
OTI Services, Italien
Kontaktperson: Roberto Novelli, MD;
-
P.O. Misericordia - Servizio di Medicina Subacquea ed Iperbarica, Italien
Kontaktperson: Marco Brauzzi, MD;
-
Poliambulatorio Day Hospital MPM, Italien
Kontaktperson: Emanuele Nasole, MD;
-
Rambam Medical Centre - Orthopedic and HBO Medical Dpt. Haifa, Israel
Kontaktperson: Yehuda Melamed, MD
Daniel Reis FRCS;
-
Servizio OTI - Insitituto Clinico, Italien
Kontaktperson: Renato Moroni, MD;
-
St. Paul's General Hospital - HBO Dpt. Thessaloniki, Griechenland
Kontaktperson: Theodore Mesimeris, MD;
- Gefördert durch
-
Europäische Kommission, Rue de la Loi, Brussels, Belgien
